Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine

www.nytimes.com
3 min read
fairly difficult
The company said its vaccine generated $3.5 billion in revenue in the first three months of this year.
The pricing for the United States was in line with the cost of seasonal flu vaccines and much less expensive than vaccines for conditions like shingles, which can run into several hundred dollars.

"That price point does not seem offensive, even if you don't spend a lot of time thinking about prescription drugs," said Stacie Dusetzina, an associate professor of health policy at Vanderbilt University Medical Center. "Just thinking about any prescription you'd fill, you'd be hard-pressed to find pretty much anything for $20."

But the fact that Pfizer appears to have earned something like $900 million in pretax profits from its vaccine — coupled with its comparatively small sales to poor countries — suggests that profits have trumped other considerations. That could…
Rebecca Robbins, Peter S. Goodman
Read full article